Thursday, November 07, 2019 2:16:17 PM
I noticed the other Marijuana stocks in a more reputable position (non OTC or non penny) are way way way over inflated. EVIO was the only one I could find that was trading at a reasonable value and at least had a balance sheet and real revenue coming in.
Also being the testing sector and the only publicly traded one at the time.
So far though I expected EVIO to be in a much better position going into 2020. Poor decisions and execution here. If the Mass lab and CBD testing were not in EVIOs near future I would be out by now.
At this point I am hopeful to be able to get my initial investment back.
There has really been no good news at all in the last 2 years.
About 3 years ago we had a really insane spike but its all been downhill since.
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM